Crossmark

Statistical analysis plan for a parallel group randomized clinical trial comparing schema therapy versus treatment as usual for outpatients with difficult-to-treat depression (DEPRE-ST)

Crossref DOI link: https://doi.org/10.1186/s13063-025-09012-4

Published Online: 2025-09-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arendt, Ida-Marie T. P. https://orcid.org/0000-0002-0889-4526
Gondan, Matthias

Juul, Sophie

Hastrup, Lene Halling

Hjorthøj, Carsten

Moeller, Stine B.
Funding

Funding for this research was provided by:

TrygFonden (149726)

Region Syddanmark (1523)

University of Southern Denmark
License Information

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-09-01
More Information

Article History

Received: 4 July 2025

Accepted: 29 July 2025

First Online: 1 September 2025

Declarations

:

: The trial has been approved by the Southern Region of Denmark Research Ethics Committee; Project ID S-20220033 for compliance with applicable research and human subjects regulation. Written consent will be obtained from all participants before inclusion.

: Not applicable.

: SBM is a practicing schema therapist and a member of the International Society for Schema Therapy (ISST). IMTPA is an affiliated member of the ISST. All other authors declare that they have no competing interests.The open access publication fee was covered by the Region of Southern Denmark Psychiatry’s publication fund.No members of the project management or project steering group have financial connections to Trygfonden or to the board of Region of Southern Denmark’s PhD-fund. The funding bodies have no influence on the design of the trial, nor the collection, analysis, or interpretation of the data.

Document is current

Any future updates will be listed below